|
| |
|
|
| |
|
+ Objects: |
|
- Protein. |
|
- DNA/RNA.
|
- Macromolecular complex (protein-ligand or protein-
protein).
|
|
| |
|
| |
|
|
|
| |
|
|
|
|
 |
|
|
|
|
The List of Kinases at Creative BioStructure |
|
|
|
Creative BioStructure has extensive experience in co-crystallization of a large number of protein kinases with small molecule compounds. Below please see the list of kinases we have been working on.
|
|
List of Protein Kinases
at Creative BioStructure |
|
Gene Symbol |
cDNA length
[bp] |
Gene Symbol |
cDNA length
[bp] |
Gene Symbol |
cDNA length
[bp] |
Gene Symbol |
cDNA length
[bp] |
|
BMX |
412-675 |
APEG1 |
342 |
EEF2K |
2178 |
ADCK4 |
1635 |
|
p38-beta |
full
length |
STK10 |
435 |
TLK1 |
2301 |
FASTK |
1650 |
|
p38-delta |
full length |
STK32A |
501 |
FES
|
2469 |
MARK3 |
2190 |
|
mkk6 |
full length |
ADCK5 |
510 |
MKNK2 |
477 |
STK4 |
120 |
|
Erk2 |
full length |
PDGFRA |
657 |
MLKL |
792 |
MASK |
414 |
|
PRAK |
full length |
PRKACB |
774 |
CSNK1G1 |
924 |
STK40 |
702 |
|
MKK1 |
full length |
TSSK6 |
822 |
BCKDK |
1008 |
CCRK |
828 |
|
PTK9L |
1050 |
CDC2 |
894 |
PDIK1L |
1026 |
STK16 |
918 |
|
CDK9 |
1119 |
CDK2 |
897 |
MAPK13 |
1098 |
MAPK12 |
1104 |
|
MAP2K2 |
1203 |
CDK4 |
912 |
TSSK1 |
1104 |
STK32C |
1110 |
|
PDK3 |
1221 |
PIM2 |
936 |
PHKG2 |
1221 |
STK17B |
1119 |
|
CSNK1G2 |
1248 |
NEK6 |
942 |
PDK4 |
1236 |
ACVR1B |
1518 |
|
STK25 |
1281 |
PBK |
969 |
RET |
1377 |
NRBP |
1608 |
|
SGK |
1296 |
CDC2L5 |
975 |
IRAK4 |
1383 |
PRKCZ |
1779 |
|
PCTK1 |
1347 |
ERBB3 |
996 |
AKT1 |
1443 |
ARAF |
1821 |
|
ZAK |
1368 |
MAP2K6 |
1005 |
CLK3 |
1473 |
EIF2AK1 |
1893 |
|
PCTK3 |
1419 |
CSNK1A1L |
1014 |
CAMKV |
1506 |
SRPK1 |
1968 |
|
CLK3 |
1473 |
TRIB2 |
1032 |
ADCK4 |
1512 |
SRPK2 |
2067 |
|
RPS6KA5 |
1650 |
CDK7 |
1041 |
MATK |
1524 |
MAPK15 |
834 |
|
RIOK1 |
1707 |
PRKD3 |
1836 |
HIPK4 |
1851 |
EPHA7 |
840 |
|
MAP3K3 |
273 |
CDK5 |
879 |
TSSK3 |
807 |
ICK |
879 |
|
EPHA4 |
318 |
Note:
For the green-colored ones, soluble proteins are available.
|
|
| |
|
Notes: |
-
Since most
protein kinases of public interest have their structures
resolved or have a homologous structure available, it is
much easier to express a kinase in a soluble functional
form [or refold it into such a form] in comparison with
novel proteins.
-
Also, we may
follow [or refer to] the published conditions to grow
the crystals, the most challenging step in
X-ray Crystallography.
-
Most
importantly, if structure of a homologous kinase is
available in the RCSB Protein Data Bank (http://www.rcsb.org/pdb/home/home.do),
the kinase-compound structure can be determined by one
good set of diffraction data with Molecular Replacement
(MR) method.
-
In contrast, if a homologous model is not available,
phase problem has to be determined by either Multiple
Isomorphous Replacement (MIR) using heavy atoms or
Multiple Wavelength Anomalous Dispersion (MAD) using
selenomethionine derivatives. Depending on the phasing
methods, more than one data set is collected.
|
|
|
|
|